- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03242122
Evaluation of Carbohydrates
August 31, 2017 updated by: Abbott Nutrition
The study is open-label with a randomized, cross-over design using standard Gl methodology.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5C 2N8
- Glycemic Index Laboratories Inc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects are males or non-pregnant females in good health.
- Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion Criteria:
- Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes or a heart condition.
- Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CHO Control 1 Glucose
25 g glucose
|
mixed in 237 ml/8 fl oz of a flavored non-caloric beverage; 1 time consumption
|
Active Comparator: CHO Control 2 Glucose
25 g glucose
|
mixed in 237 ml/8 fl oz of a flavored non-caloric beverage; 1 time consumption
|
Experimental: CHO Experimental 1 Slowly Digested
25 g slowly-digested carbohydrate blend
|
mixed in 237 ml/8 fl oz of a flavored non-caloric beverage; 1 time consumption
|
Experimental: CHO Experimental 2 Digestion Resistant
25 g digestion-resistant carbohydrate blend
|
mixed in 237 ml/8 fl oz of a flavored non-caloric beverage; 1 time consumption
|
Experimental: CHO Experimental 3 Low Sugar
25 g low sugar carbohydrate blend
|
mixed in 237 ml/8 fl oz of a flavored non-caloric beverage; 1 time consumption
|
Experimental: CHO Experimental 4 Maltodextrin
25 g maltodextrin
|
mixed in 237 ml/8 fl oz of a flavored non-caloric beverage; 1 time consumption
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood glucose response curve
Time Frame: 0 to 120 minutes
|
area under the curve (AUG)
|
0 to 120 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 17, 2017
Primary Completion (Actual)
August 18, 2017
Study Completion (Actual)
August 18, 2017
Study Registration Dates
First Submitted
July 31, 2017
First Submitted That Met QC Criteria
August 3, 2017
First Posted (Actual)
August 8, 2017
Study Record Updates
Last Update Posted (Actual)
September 1, 2017
Last Update Submitted That Met QC Criteria
August 31, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- BL37 Part 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Index
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
Aga Khan UniversityUnknown
-
PepsiCo Global R&DCompletedGlycemic IndexUnited States
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Arizona State UniversityStandard Process Inc.Terminated
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Unknown
-
Nutrition Institute, SloveniaSlovenian Research Agency; Valens Int. d.o.o., Slovenija; Community Health Centre...CompletedGlycemic IndexSlovenia
-
Azienda di Servizi alla Persona di PaviaRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
Clinical Trials on CHO Control 1 and 2 Glucose
-
Weill Medical College of Cornell UniversityEnrolling by invitationGestational DiabetesUnited States
-
Claudia M. WittCompleted
-
Imperial College LondonCompleted
-
Guangzhou Patronus Biotech Co., Ltd.Yantai Patronus Biotech Co., Ltd.Terminated
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.Completed
-
Clinical Nutrition Research Centre, SingaporeBarilla Singapore Pte LtdCompleted
-
National Vaccine and Serum Institute, ChinaZhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...Active, not recruiting
-
HaEmek Medical Center, IsraelHoly Family Hospital, Nazareth, IsraelRecruitingPregnancy in Diabetics | Obstetric LaborIsrael
-
Danone Asia Pacific Holdings Pte, Ltd.Nutricia ResearchCompleted